PC
PointState Capital Portfolio holdings
AUM
$4.67B
This Quarter Return
+3.58%
1 Year Return
+24.63%
3 Year Return
+80.28%
5 Year Return
+158.5%
10 Year Return
+665.76%
AUM
$3.24B
AUM Growth
+$3.24B
(-23%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-33.74%
Top 10 Holdings %
Top 10 Hldgs %
57.93%
Holding
158
New
35
Increased
19
Reduced
31
Closed
52
Top Buys
| 1 |
D.R. Horton
DHI
|
$173M |
| 2 |
Aptiv
APTV
|
$73.8M |
| 3 |
Booking.com
BKNG
|
$73.5M |
| 4 |
Samsara
IOT
|
$62.9M |
| 5 |
SentinelOne
S
|
$62.6M |
Top Sells
| 1 |
Allstate
ALL
|
$220M |
| 2 |
Palo Alto Networks
PANW
|
$180M |
| 3 |
Fiserv
FI
|
$131M |
| 4 |
WillScot Mobile Mini Holdings
WSC
|
$126M |
| 5 |
Wells Fargo
WFC
|
$121M |
Sector Composition
| 1 | Technology | 41.58% |
| 2 | Consumer Discretionary | 23.48% |
| 3 | Communication Services | 11.73% |
| 4 | Healthcare | 7.17% |
| 5 | Industrials | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
51
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.91M | 0.11% | 44,700 -20,300 | -31% | -$3.14M |
|
52
Procept Biorobotics
PRCT
$2.23B
| $6.77M | 0.11% | 270,860 -4,100 | -1% | -$103K |
|
53
Boston Scientific
BSX
$156B
| $6.41M | 0.11% | 151,000 -19,000 | -11% | -$807K |
|
54
Zimmer Biomet
ZBH
$21B
| $6.35M | 0.11% | 50,000 -15,800 | -24% | -$2.01M |
|
55
Magna International
MGA
$12.9B
| $5.94M | 0.1% | +73,425 | New | +$5.94M |
|
56
Elanco Animal Health
ELAN
$9.12B
| $5.68M | 0.09% | 200,000 -77,300 | -28% | -$2.19M |
|
57
Eli Lilly
LLY
$657B
| $5.52M | 0.09% | 20,000 -20,000 | -50% | -$5.52M |
|
58
Merck
MRK
$210B
| $5.37M | 0.09% | 70,000 -495,925 | -88% | -$38M |
|
|
WBA
59
DELISTED
Walgreens Boots Alliance
WBA
| $5.22M | 0.09% | +100,000 | New | +$5.22M |
|
60
Intel
INTC
$107B
| $5.15M | 0.09% | 100,000 | – | – |
|
61
Labcorp
LH
$23.1B
| $5.12M | 0.08% | 16,300 -27,200 | -63% | -$8.55M |
|
62
Alnylam Pharmaceuticals
ALNY
$58.5B
| $5.09M | 0.08% | 30,000 +18,000 | +150% | +$3.05M |
|
63
Biogen
BIIB
$19.4B
| $5.04M | 0.08% | 21,000 -44,500 | -68% | -$10.7M |
|
64
GSK
GSK
$79.9B
| $4.85M | 0.08% | 110,000 -98,500 | -47% | -$4.34M |
|
65
Bristol-Myers Squibb
BMY
$96B
| $4.83M | 0.08% | +77,500 | New | +$4.83M |
|
66
SPDR S&P Metals & Mining ETF
XME
$2.31B
| $4.48M | 0.07% | +100,000 | New | +$4.48M |
|
67
Toll Brothers
TOL
$13.4B
| $4.45M | 0.07% | +61,445 | New | +$4.45M |
|
68
KB Home
KBH
$4.32B
| $4.2M | 0.07% | +93,965 | New | +$4.2M |
|
69
Viatris
VTRS
$12.3B
| $4.06M | 0.07% | +300,000 | New | +$4.06M |
|
70
Vertex Pharmaceuticals
VRTX
$100B
| $3.84M | 0.06% | +17,500 | New | +$3.84M |
|
71
Medtronic
MDT
$119B
| $3.62M | 0.06% | 35,000 -5,000 | -13% | -$517K |
|
|
SYNH
72
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.59M | 0.06% | +35,000 | New | +$3.59M |
|
73
argenx
ARGX
$43.6B
| $3.57M | 0.06% | 10,200 +5,100 | +100% | +$1.79M |
|
74
CF Industries
CF
$14B
| $3.5M | 0.06% | +49,495 | New | +$3.5M |
|
|
HZNP
75
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.69M | 0.04% | 25,000 -20,000 | -44% | -$2.16M |
|